Empowered Funds LLC Acquires Shares of 45,177 Nutex Health Inc. $NUTX

Key Points

• Empowered Funds LLC initiated a position in Nutex Health by purchasing 45,177 shares valued at approximately $7.72 million, representing about 0.66% of the company. Institutional investors and hedge funds collectively own 5.32% of NUTX.
• Analyst sentiment is broadly positive: Nutex Health has an average “Buy” rating and a consensus price target of $300, with recent targets ranging from $290 to $310.
• Nutex Health reported quarterly EPS of $9.38, beating the $4.95 consensus estimate, while revenue of $210.75 million fell slightly short of expectations. Shares opened at $189.25, near their 52-week high of $204.00.

Empowered Funds LLC bought a new position in shares of Nutex Health Inc. (NASDAQ:NUTX - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 45,177 shares of the company's stock, valued at approximately $7,720,000. Empowered Funds LLC owned approximately 0.66% of Nutex Health as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of NUTX. Kilter Group LLC acquired a new stake in Nutex Health in the 2nd quarter valued at about $27,000. Allworth Financial LP acquired a new position in shares of Nutex Health during the 2nd quarter worth approximately $35,000. Islay Capital Management LLC purchased a new stake in shares of Nutex Health in the fourth quarter valued at approximately $34,000. BNP Paribas Financial Markets grew its position in shares of Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company's stock valued at $40,000 after purchasing an additional 290 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in shares of Nutex Health by 752.4% in the fourth quarter. Royal Bank of Canada now owns 358 shares of the company's stock valued at $59,000 after purchasing an additional 316 shares during the last quarter. 5.32% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Zacks Research upgraded Nutex Health from a "hold" rating to a "strong-buy" rating in a report on Monday, August 24th. Weiss Ratings raised shares of Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a report on Tuesday, July 28th. B. Riley Financial started coverage on shares of Nutex Health in a research report on Friday, June 26th. They set a "buy" rating and a $290.00 price objective for the company. Wall Street Zen downgraded shares of Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Monday, July 20th. Finally, Lake Street Capital reiterated a "buy" rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus price target of $300.00.

Nutex Health Stock Performance

Shares of NUTX stock opened at $189.25 on Monday. Nutex Health Inc. has a 1-year low of $77.21 and a 1-year high of $204.00. The firm has a market cap of $1.30 billion, a PE ratio of 7.43 and a beta of 0.24. The company has a 50-day moving average of $171.62 and a two-hundred day moving average of $133.84. The company has a debt-to-equity ratio of 0.59, a current ratio of 5.00 and a quick ratio of 4.96.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.95 by $4.43. The company had revenue of $210.75 million for the quarter, compared to analyst estimates of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. On average, analysts predict that Nutex Health Inc. will post 30.11 EPS for the current year.

Nutex Health Company Profile

Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

Want to see what other hedge funds are holding NUTX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nutex Health Inc. (NASDAQ:NUTX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source